Valiant Laboratories Limited (VALIANTLAB.NS)
INR 128.1
(14.76%)
INR 128.1
(14.76%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 138.02 Million INR | -75.61% |
| 2022 | 565.9 Million INR | 8.16% |
| 2021 | 523.21 Million INR | -10.39% |
| 2020 | 583.9 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -1.17 Million INR | -120.03% |
| 2023 Q2 | 47.32 Million INR | -48.01% |
| 2023 FY | 138.02 Million INR | -75.61% |
| 2023 Q4 | 5.84 Million INR | 195.07% |
| 2023 Q3 | -6.14 Million INR | -112.99% |
| 2023 Q1 | 91.01 Million INR | 0.17% |
| 2022 FY | 565.9 Million INR | 8.16% |
| 2022 Q4 | 90.85 Million INR | -41.92% |
| 2022 Q3 | 156.44 Million INR | -1.39% |
| 2022 Q2 | 158.64 Million INR | 0.0% |
| 2021 FY | 523.21 Million INR | -10.39% |
| 2020 FY | 583.9 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | 93.106% |
| Ind-Swift Limited | 2.17 Billion INR | 93.647% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 90.622% |
| Sakar Healthcare Limited | 699.58 Million INR | 80.27% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 99.874% |
| Innova Captab Limited | 3.46 Billion INR | 96.016% |
| Divi's Laboratories Limited | 32.44 Billion INR | 99.575% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 97.782% |
| Morepen Laboratories Limited | 6.16 Billion INR | 97.76% |
| Mankind Pharma Limited | 42.19 Billion INR | 99.673% |
| Sequent Scientific Limited | 2.97 Billion INR | 95.366% |
| Wanbury Limited | 1.73 Billion INR | 92.024% |
| Laurus Labs Limited | 15.44 Billion INR | 99.107% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 97.138% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 98.89% |
| Alembic Limited | 1 Billion INR | 86.199% |
| Hikal Limited | 5.95 Billion INR | 97.683% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.485% |
| Neuland Laboratories Limited | 8.24 Billion INR | 98.326% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 99.095% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.801% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 97.075% |
| Themis Medicare Limited | 2.42 Billion INR | 94.296% |
| RPG Life Sciences Limited | 2.48 Billion INR | 94.441% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.89% |
| Lupin Limited | 125.09 Billion INR | 99.89% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 93.408% |
| Wockhardt Limited | 7.72 Billion INR | 98.212% |
| Vaishali Pharma Limited | 90.32 Million INR | -52.817% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 97.633% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 78.849% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 99.297% |
| FDC Limited | 6.58 Billion INR | 97.904% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.916% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 77.754% |
| Eris Lifesciences Limited | 10.42 Billion INR | 98.676% |
| Venus Remedies Limited | 2.18 Billion INR | 93.676% |
| ZIM Laboratories Limited | 1.26 Billion INR | 89.113% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 96.265% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | 73.914% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 98.501% |
| Shilpa Medicare Limited | 3.56 Billion INR | 96.125% |
| Albert David Limited | 1.4 Billion INR | 90.197% |
| Ajanta Pharma Limited | 21.06 Billion INR | 99.345% |
| Hester Biosciences Limited | 1.27 Billion INR | 89.163% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 96.652% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 108.336% |
| Gufic Biosciences Limited | 4.07 Billion INR | 96.612% |
| Windlas Biotech Limited | 1.33 Billion INR | 89.69% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 97.613% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -22.118% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | 80.03% |
| Granules India Limited | 16.79 Billion INR | 99.178% |
| Aarti Drugs Limited | 8.31 Billion INR | 98.34% |
| Bal Pharma Limited | 770.19 Million INR | 82.079% |
| Alkem Laboratories Limited | 52.29 Billion INR | 99.736% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.947% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 92.685% |
| Medicamen Biotech Limited | 495.49 Million INR | 72.143% |
| Unichem Laboratories Limited | 4.86 Billion INR | 97.163% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | 69.473% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -1000.271% |
| Orchid Pharma Limited | 2.32 Billion INR | 94.051% |
| Medico Remedies Limited | 262.14 Million INR | 47.346% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 96.66% |
| Ipca Laboratories Limited | 48.58 Billion INR | 99.716% |
| Brooks Laboratories Limited | 65.62 Million INR | -110.346% |
| Syncom Formulations (India) Limited | 559.5 Million INR | 75.33% |
| Piramal Enterprises Limited | 8.04 Billion INR | 98.284% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.705% |
| NATCO Pharma Limited | 25.73 Billion INR | 99.464% |
| Suven Life Sciences Limited | -200.79 Million INR | 168.741% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 226.927% |
| Strides Pharma Science Limited | 14.38 Billion INR | 99.041% |
| Indoco Remedies Limited | 8.04 Billion INR | 98.284% |
| Alpa Laboratories Limited | 188.89 Million INR | 26.928% |
| Lasa Supergenerics Limited | 121.02 Million INR | -14.045% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 64.704% |